2-236167514-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001485.4(GBX2):c.458G>A(p.Gly153Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000276 in 1,594,926 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001485.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GBX2 | NM_001485.4 | c.458G>A | p.Gly153Asp | missense_variant | Exon 1 of 2 | ENST00000306318.5 | NP_001476.2 | |
GBX2 | NM_001301687.2 | c.458G>A | p.Gly153Asp | missense_variant | Exon 1 of 3 | NP_001288616.1 | ||
GBX2 | XM_047443907.1 | c.458G>A | p.Gly153Asp | missense_variant | Exon 1 of 4 | XP_047299863.1 | ||
GBX2-AS1 | NR_186035.1 | n.73C>T | non_coding_transcript_exon_variant | Exon 1 of 2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152118Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000909 AC: 2AN: 219936Hom.: 0 AF XY: 0.00000819 AC XY: 1AN XY: 122132
GnomAD4 exome AF: 0.0000256 AC: 37AN: 1442808Hom.: 0 Cov.: 34 AF XY: 0.0000265 AC XY: 19AN XY: 717902
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152118Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74304
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.458G>A (p.G153D) alteration is located in exon 1 (coding exon 1) of the GBX2 gene. This alteration results from a G to A substitution at nucleotide position 458, causing the glycine (G) at amino acid position 153 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at